DataMEDS AI (MEDS) Stock News
$MEDS · NASDAQ · 1 stories in 30 daysBORSA has published 1 story on DataMEDS AI (MEDS) in the past 30 days. BORSA’s news read on MEDS is bullish at 69/100, based on 1 company event over the past 7 days. MEDS last closed at $2.67 on Oct 19, down 13.03% over five sessions and down 28.99% over the past month. DataMEDS AI’s next earnings report is scheduled for Wednesday, Nov 18.
The wire on $MEDS
newest first · updated · direct subject stories onlyDataMeds AI received a notice from Nasdaq that it has regained compliance with the minimum stockholders' equity requirement of $2.5 million. The company had previously regained bid-price compliance in June. Continued listing depends on maintaining compliance in future filings.
bullish 75 · impact 30The wire on this name is open. What the tape did about it is one free account away.
One free account opens every story complete, the live board and the 30-day calendar, and 3 complete ticker and report views a day. No card. The wire stays free to read.
DataMEDS AI (MEDS) stock: common questions
What is the latest DataMEDS AI stock news?
The highest-impact MEDS story BORSA published in the past 30 days:
· DataMeds AI regains compliance with Nasdaq listing standards